$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
贝罗司他美国获批预防遗传性血管性水肿(HAE)发作
2025-10-19 11:44:20
Check Details
预防遗传性血管水肿发作:贝罗司他胶囊显奇效
2025-10-19 11:44:20
Check Details
一直以来,你真的用对贝罗司他胶囊了吗?
2025-10-19 11:44:20
Check Details
贝罗司他胶囊多少钱一盒?在合肥能买到贝罗司他胶囊吗
2025-10-19 11:44:20
Check Details
贝罗司他胶囊治疗效果如何?用多长时间能见到效果
2025-10-19 11:44:20
Check Details
贝罗司他胶囊可预防遗传性血管性水肿!
2025-10-19 11:44:20
Check Details
日本厚生劳动省批准贝罗司他胶囊用于遗传性血管性水肿的预防性治疗!
2025-10-19 11:44:20
Check Details
Lanadelumab可有效降低遗传性血管性水肿患者的发病率
2025-10-19 11:44:20
Check Details
日本批准贝罗司他用于遗传性血管性水肿的预防性治疗
2025-10-19 11:44:20
Check Details
贝罗司他胶囊怎么使用?副作用是什么?
2025-10-19 11:44:20
Check Details
贝罗司他胶囊作用功效是什么?贝罗司他胶囊应该如何使用
2025-10-19 11:44:20
Check Details
奥拉迪约价格多少?奥拉迪约有什么副作用
2025-10-19 11:44:20
Check Details
1
2
...
5520
5521
5522
5523
5524
5525
5526
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
2
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
3
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor
4
Is Eplerenone Suitable for Long-Term Use?
5
Does Ixazomib (Ninlaro) Require Long-Term Use to Be Effective?
6
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
7
What is the effectiveness of the new weapon for myeloma patients: cetuximab? Listen to what the user has to say
8
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).
9
What diseases can Upatinib be used for? Which patients are suitable for use?
10
The efficacy of Eltrombopag
11
User Agreement
12
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks